Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Neuphoria Therapeutics Inc NEUP

Healthcare Biotechnology
Neuphoria Therapeutics Inc., a clinical stage biopharmaceutical company, discovers and develops novel allosteric ion channel modulators for the treatment of central nervous system disorders in Australia. Its lead product candidate includes BNC210, a selective negative allosteric modulator of the a7 for the treatment of social anxiety disorder; and is phase 2b to treat post-traumatic stress... see more

Current News (NDAQ:NEUP)

Leading Proxy Advisory Firm ISS Recommends that Shareholders Vote the WHITE Proxy Card FOR Both of Neuphoria's Director Nominees

GlobeNewswire December 8, 2025

Neuphoria Responds to Lynx1's Revised Indication of Interest at a Reduced Price and Premium

GlobeNewswire December 4, 2025

Neuphoria Provides Facts, Exposes False Narratives in Response to Lynx1 Fictions

GlobeNewswire December 1, 2025

Neuphoria Therapeutics Inc. Sends Letter to Stockholders

GlobeNewswire November 24, 2025

Neuphoria Announces Initiation of Strategic Review to Maximize Stockholder Value

GlobeNewswire November 11, 2025

Neuphoria Therapeutics Adopts Limited-Duration Stockholder Rights Plan to Protect Integrity of Process

GlobeNewswire October 27, 2025

Neuphoria Therapeutics Provides Update on AFFIRM-1 Phase 3 Trial Evaluating BNC210 for the Acute Treatment of Social Anxiety Disorder

GlobeNewswire October 20, 2025

Neuphoria Provides Fiscal Year-End 2025 Financial Results and Business Updates

GlobeNewswire September 29, 2025

Neuphoria Therapeutics Completes Target Enrollment in Phase 3 AFFIRM-1 Trial of BNC-210 in Social Anxiety Disorder (SAD)

GlobeNewswire September 4, 2025
View More News ››

Opinion & Analysis (NDAQ:NEUP)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:NEUP)

NEUP......Scalp City !

4 scalps in the 1st 1/2 hour of the opening bell...lol....shoulda just kept my original buy oda ; ) But thanks to all The Chasers &...
Iseneschal - October 24, 2025

Buy buddy buy.

Otherwise it will be FOMO time for you fellas out there today anyway,so good luck to all
coolfooldumbguy - October 24, 2025

RE:NEUP....trading at ~ $5 1/2 hr before opening bell

That didn't happen....Just a Green to Red move Announce the P.O for **** Sakes
Iseneschal - February 12, 2025

NEUP....trading at ~ $5 1/2 hr before opening bell

Not trading this but..... I can see this rallying during Regular hours trading...mainly to bury The Greater Fool with high priced paper ...
Iseneschal - February 12, 2025

NEUP....NR might be a "smoke screen" for a financing

IMHO
Iseneschal - February 12, 2025

NEUP....Lokks like a break of $6.20 would meaningful

Lots of gyrations yesterday Better volume today No position
Iseneschal - February 12, 2025
View more Bullboard ››

DRC Gold Corp.

DRC Gold Corp.

DRC Gold Corp. is an exploration and development company formed for the purposes of acquiring, exploring and if warranted and ...
View More »

Podcasts